Abiopharma

OTC Markets Group Welcomes Orvana Minerals Corp. to OTCQX

Legence Reports Fourth Quarter and Year End 2025 Financial Results

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

Forgent Power Solutions Announces Pricing of Public Offering of Class A Common Stock

Green Stream Holdings, Inc. Announces New Leadership and Board Appointments and Strategic Direction Involving Law90 and Subsidiaries

Hudbay Provides Annual Reserve and Resource Update with Mine Life Extensions and Improved Three-Year Production Outlook

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

Aurora Mobile Partners with Soochow Securities to Advance Digital Transformation and Develop Intelligent Financial Services Platform

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)